Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Clinical Endocrinology and Metabolism|August 22, 2014
Combination of peptide YY3-36 with GLP-1(7-36) amide causes an increase in first-phase insulin secretion after IV glucoseTricia M Tan, Victoria Salem, Rachel C Troke, et al.
British Journal of Clinical Pharmacology|August 13, 2011
Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420Tricia M Tan, Benjamin C T Field, James S Minnion, et al.
Diabetes|June 19, 2014
Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intakeJaimini Cegla, Rachel C Troke, Ben Jones, et al.
Molecular Metabolism|May 2, 2021
Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonistPhil Pickford, Maria Lucey, Roxana-Maria Rujan, et al.
Diabetes|December 19, 2012
Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemiaTricia M Tan, Benjamin C T Field, Katherine A McCullough, et al.
The Lancet. Diabetes & Endocrinology|June 9, 2019
Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trialAlexander Dimitri Miras, Belén Pérez-Pevida, Madhawi Aldhwayan, et al.
Diabetes Care|June 10, 2019
Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled StudyPreeshila Behary, George Tharakan, Kleopatra Alexiadou, et al.
BMJ Open Diabetes Research & Care|January 7, 2021
Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitalsChioma Izzi-Engbeaya, Walter Distaso, Anjali Amin, et al.
Nature Genetics|September 7, 2023
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratificationVasiliki Lagou, Longda Jiang, Anna Ulrich, et al.
Pageof 3